Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

25

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

Tags:

Previous Article

Immunotherapy for difficult-to-treat brain tumors with gut microbiota

Role of plasmin in metastatic tumors

Related Posts

GDF15 is still a mystery hormone

GDF15 is still a mystery hormone

44

A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T Cell proliferation and anti-tumor immunity in mice

A bispecific CD40 agonistic antibody allowing for antib...

68

The intersection between metabolism and translation through a subcellular lens

The intersection between metabolism and translation thr...

77